Sort
1,049,261 grants matching “t cell”
RNA Programmable and Scalable Brain Cell Type Tools Across Vertebrates
$3,138,556Z Josh Huang · Duke University · U01 · FY2025 · MH
EXPLORER: Changing the Molecular Imaging Paradigm with Total Body PET
$3,138,069Ramsey D. Badawi · University Of California At Davis · R01 · FY2017 · CA
Molecular Genetics of Endocrine Tumors and Related Disorders
$3,137,149Constantine A. Stratakis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
An AAV-mediated functional cure and its impact on the reservoir
$3,136,852Michael R. Farzan · University Of Florida · U19 · FY2022 · AI
Short Sleep: Locus Coeruleus Metabolics and the Temporal Progression of Alzheimers
$3,136,625Sigrid C Veasey · University Of Pennsylvania · RF1 · FY2016 · AG
Optimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization
$3,136,427Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2020 · DA
Louisiana Biomedical Research Network (LBRN)
$3,136,420Thomas R. Klei · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2010 · RR
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE)
$3,136,008Laurence Katznelson · Stanford University · N02 · FY2025 · HL
NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network
$3,135,983Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2015 · CA
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease
$3,135,849Arthur W Toga · University Of Southern California · P01 · FY2025 · AG
ApoE2 in Alzheimer's disease: the neuroprotective effects and mechanisms
$3,134,935Yanhong Shi · Beckman Research Institute/City Of Hope · RF1 · FY2018 · AG
PHARMACOGENETICS OF ANTICANCER AGENTS RESEARCH GROUP
$3,134,884University Of Chicago · U01 · FY2004 · GM
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,134,725William Childs · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Cancer Risk in Human Populations
$3,133,984Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
The regulation of synaptic transmission and neural circuit function
$3,133,617Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
A NOVEL INTERMEDIATE-TEMPERATURE BIFUNCTIONAL CERAMIC FUEL CELL ENERGY SYSTEM
$3,133,408University Of South Carolina · · FY2014 · Department of Energy
Structural Studies Of Post-Transcriptional Gene Regulation
$3,133,110Traci M Hall · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Novel Tools and Approaches Research Program
$3,133,107David Crizer · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)
$3,132,917Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
South Dakota Biomedical Research Infrastructure Network
$3,132,597Barbara E Goodman · University Of South Dakota · P20 · FY2011 · RR
Fluorescent Biosensors for Networks and Pathways
$3,132,385Alan S Waggoner · Carnegie-Mellon University · U54 · FY2011 · RR
FLUORESCENT BIOSENSORS FOR NETWORKS AND PATHWAYS
$3,132,385Alan S Waggoner · Carnegie-Mellon University · U54 · FY2011 · RR
Mechanisms of Functional Vascular Impairment In Genetic Models of Cerebral Small Vessel Disease
$3,132,152Douglas Gould · University Of California, San Francisco · RF1 · FY2018 · NS
Lymphoid-specific high-efficiency beta-catenin protein degradation
$3,131,408Markus Mãschen · Yale University · R01 · FY2025 · AI
Functional Genomics of Bipolar Disorder
$3,131,235Francis J McMahon · National Institute Of Mental Health · ZIA · FY2022 · MH